Australia - inglese - Department of Health (Therapeutic Goods Administration)

rad data australia pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Israele - inglese - Ministry of Health

neurim pharmaceuticals (1991) ltd, israel - melatonin - tablets prolonged release - melatonin 2 mg - melatonin - short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; purified talc; ammonio methacrylate copolymer; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Belgio - inglese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vemedia manufacturing b.v. - melatonin 3 mg - tablet - 3 mg - melatonin 3 mg - melatonin

Belgio - inglese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vemedia manufacturing b.v. - melatonin 5 mg - tablet - 5 mg - melatonin 5 mg - melatonin

Australia - inglese - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc; ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - melatonin, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; sorbitol solution (70 per cent) (non-crystallising); sucralose; hydrochloric acid; purified water; flavour - adult,short-term treatment of jet lag in adults aged 18 and over.,paediatric,sleep disorders in children and adolescents aged 6 to 18 with neurodevelopmental disorders including autism spectrum disorder (asd) and attention deficit hyperactivity disorder (adhd), where sleep hygiene measures have been insufficient.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - melatonin, quantity: 2 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; povidone; maltodextrin; magnesium stearate; titanium dioxide; indigo carmine; gelatin - adult,short-term treatment of jet lag in adults aged 18 and over.,paediatric,sleep disorders in children and adolescents aged 6 to 18 with neurodevelopmental disorders including autism spectrum disorder (asd) and attention deficit hyperactivity disorder (adhd), where sleep hygiene measures have been insufficient.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - melatonin, quantity: 3 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; povidone; maltodextrin; magnesium stearate; titanium dioxide; gelatin - adult,short-term treatment of jet lag in adults aged 18 and over.,paediatric,sleep disorders in children and adolescents aged 6 to 18 with neurodevelopmental disorders including autism spectrum disorder (asd) and attention deficit hyperactivity disorder (adhd), where sleep hygiene measures have been insufficient.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - melatonin, quantity: 5 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; povidone; maltodextrin; magnesium stearate; titanium dioxide; gelatin; indigo carmine - adult,short-term treatment of jet lag in adults aged 18 and over.,paediatric,sleep disorders in children and adolescents aged 6 to 18 with neurodevelopmental disorders including autism spectrum disorder (asd) and attention deficit hyperactivity disorder (adhd), where sleep hygiene measures have been insufficient.